Table 3 Results of T test and prediction modeling.
From: Expression signatures of TP53 mutations in serous ovarian cancers
Comparison | N | Misclassified | Accuracy | # Probes | P threshold | #Probes < 0.05 |
|---|---|---|---|---|---|---|
Mutant v WT (all stages) | 89 | 11 | 87.6% | 9 | ≤0.05 | 9 |
Missense v WT (all stages) | 70 | 8 | 88.6% | 21 | ≤0.11 | 1 |
Missense v Null (all stages) | 59 | 8 | 86.4% | 29 | ≤0.02 | 241 |
Mutant v WT (stage III/IV)) | 49 | 5 | 89.8% | 68 | ≤0.14 | 0 |
Missense v WT (III/IV) | 45 | 5 | 88.9% | 17 | ≤0.07 | 1 |
Mutant v WT (stage I/II) | 40 | 4 | 90% | 42 | ≤0.36 | 0 |
Missense v WT (I/II) | 25 | 1 | 96% | 28 | ≤0.85 | 0 |
Null v WT (I/II) | 24 | 2 | 91.7% | 889 | ≤0.15 | 0 |